Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature. [electronic resource]
Producer: 20070405Description: 197-198 p. digitalISSN:- 0923-7534
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.